Mycoplasma hominis infection of the central nervous system in newborn infants

Insights

Central nervous system infections in newborns caused by Mycoplasma hominis can lead to meningitis or meningoencephalitis. While some infants recover, others may experience severe sequelae, though antibiotic therapy can be effective.

Area of Science:

  • Neonatal infectious diseases
  • Neuroscience
  • Microbiology

Background:

  • Mycoplasma hominis infections in the central nervous system (CNS) of neonates are not well-characterized.
  • These infections occur in both full-term and premature infants, sometimes associated with congenital malformations like myelomeningocele.
  • M. hominis has been identified in cases of brain abscesses.

Purpose of the Study:

  • To describe the clinical presentation, cerebrospinal fluid (CSF) findings, and outcomes of central nervous system infections caused by Mycoplasma hominis in newborn infants.
  • To evaluate the efficacy of antibiotic therapy in treating these infections.

Main Methods:

  • Case series or retrospective review of neonatal patients diagnosed with CNS infections.
  • Analysis of clinical data, including symptoms, neurological signs, and congenital anomalies.
  • Cerebrospinal fluid analysis for Mycoplasma hominis detection, glucose, protein, and cell counts.
  • Assessment of treatment regimens and patient outcomes.

Main Results:

  • Infected infants typically present with signs of meningitis or meningoencephalitis, with potential development of hydrocephalus.
  • Cerebrospinal fluid analysis often reveals reduced glucose, elevated protein, and high white blood cell counts (mononuclear or polymorphonuclear predominance).
  • Mycoplasma hominis was isolated from CSF when other bacteria were absent; outcomes varied, with some infants succumbing to infection, others recovering fully, and some developing sequelae like hemiplegia despite treatment.

Conclusions:

  • Mycoplasma hominis represents a significant cause of CNS infections in neonates, presenting with diverse clinical manifestations and outcomes.
  • Early diagnosis and appropriate antibiotic therapy, such as tetracycline or lincomycin, are crucial for eradicating the organism from CSF and improving patient prognosis.
  • Despite effective treatment, long-term neurological sequelae can occur, highlighting the importance of continued monitoring and supportive care.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...